Standout Papers

Ambrisentan for the Treatment of Pulmonary Arterial Hypertension 2008 2026 2014 2020 766
  1. Ambrisentan for the Treatment of Pulmonary Arterial Hypertension (2008)
    Nazzareno Galiè, Horst Olschewski et al. Circulation
  2. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity (2015)
    Deborah Siegal, John T. Curnutte et al. New England Journal of Medicine
  3. Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients (2016)
    Alexander Cohen, Robert A. Harrington et al. New England Journal of Medicine

Immediate Impact

10 by Nobel laureates 9 from Science/Nature 59 standout
Sub-graph 1 of 19

Citing Papers

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
2020 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
6 intermediate papers

Works of Brian L. Wiens being referenced

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
2015 Standout
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
2008 Standout

Author Peers

Author Last Decade Papers Cites
Brian L. Wiens 486 256 1758 877 716 48 4.1k
Lei Shen 171 20 1680 273 348 114 6.2k
Zhezhen Jin 675 59 2786 1208 75 250 6.8k
John D. Seeger 281 7 787 422 138 144 5.3k
Hajime Uno 970 51 1443 1230 60 185 8.2k
John Stevens 578 169 449 312 211 113 3.8k
E. Niclas Jonsson 846 144 384 711 37 86 6.0k
S. M. Lewis 53 98 277 741 179 201 5.7k
M. Sesmu Arbous 95 29 680 552 1104 109 6.8k
Jason T. Connor 277 74 335 460 42 66 3.5k
Andrea Marshall 172 31 962 853 993 63 3.5k

All Works

Loading papers...

Rankless by CCL
2026